Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...

Waters Highlights Continued Progress Towards Sustainability Commitments

Waters Highlights Continued Progress Towards Sustainability Commitments

News Summary: Exceeded its goal of reducing Scope 1 and 2 greenhouse gas emissions by 36% from a 2016 baseline, two years ahead of schedule. Invested in STEM education through the Waters Student Academy and Waters internship program, reaching...

From Innovation to Integrity: Bybit's Take on Digital Asset Regulation at VTIS 2024

From Innovation to Integrity: Bybit's Take on Digital Asset Regulation at VTIS 2024

DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, was a prominent participant at the Vietnam Tech Impact Summit (VTIS 2024) in early December. The event brought together global...

Arcfra Partner Day 2024 Successfully Held in Seoul

Arcfra Partner Day 2024 Successfully Held in Seoul

SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ -- Arcfra Pte. Ltd. (hereinafter referred to as "Arcfra," arcfra.com), a leading innovator in cloud infrastructure and full-stack solutions, hosted its first event for Korean partners on November 27th...

IASO Bio Presented Study Findings on the Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma with Equecabtagene Autoleucel(FUCASO) Myeloma at 2024 ASH

IASO Bio Presented Study Findings on the Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma with Equecabtagene Autoleucel(FUCASO) Myeloma at 2024 ASH

SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 10, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies...

U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025

U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025

Third-generation member of Thailand's Charoen Pokphand Group and Fortune magazine owner reinforces commitment to U Power's innovative EV battery solutions SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- U Power Limited (the "Company" or "U Power"), today...

Guangzhou and Aksu Spotlight Cultural Heritage at the 2024 Understanding China Conference

Guangzhou and Aksu Spotlight Cultural Heritage at the 2024 Understanding China Conference

Empowering global youth through cultural exchange and heritage preservation GUANGZHOU, China, Dec. 6, 2024 /PRNewswire/ -- Guangzhou hosted the 2024 Understanding China Conference, organized by China Institute for Innovation & Development...

Squirrel Ai Learning Sets Guinness World Record for "The most users to take an online mathematics lesson in 24 hours"

Squirrel Ai Learning Sets Guinness World Record for "The most users to take an online mathematics lesson in 24 hours"

SHANGHAI, Dec. 5, 2024 /PRNewswire/ -- On September 21, 2024, Squirrel Ai Learning hosted a Guinness World Record™ challenge, attracting 112,718 students across China to join an online math lesson. This unprecedented participation secured a new...

Outlook for, benefits of high-quality development in spotlight

Outlook for, benefits of high-quality development in spotlight

BEIJING, Dec. 6, 2024 /PRNewswire/ -- The article has been published by China Daily on Dec. 6: Qu Yingpu (second from right), publisher and editor-in-chief of China Daily, Qiu Xiaoping (first from left), vice-chairman of the All-China Federation of...

Sungrow Hydrogen: achieved "high-performance" + "low-cost" with technological innovation

Sungrow Hydrogen: achieved "high-performance" + "low-cost" with technological innovation

SHANGHAI, Dec. 6, 2024 /PRNewswire/ -- On the 3rd of December, BloombergNEF Summit grandly opened in Shanghai. Peng Chaocai, Chairman of Sungrow Hydrogen, was invited to attend the pivotal dialogue of "Green Hydrogen: A Reality Check" with other...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu